Combined BAC Transgenic and Knock-Out Mouse Model of Lowe Syndrome Nephropathy

Lowe 综合征肾病的 BAC 转基因和敲除小鼠模型相结合

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Lowe OculoCerebroRenal syndrome of (LOCR) is a rare X-linked disorder of congenital cataracts, mental retardation, behavioral abnormalities, and renal tubulopathy. The disease is caused by loss-of-function mutations in the OCRL gene, which encodes Ocrl, a phosphatidylinositol(4,5)P2 5-phosphatase located in the trans-Golgi network, endosomes, plasma membrane ruffles, and clathrin-coated pits. The renal tubular abnormalities of LOCR, particularly low molecular weight (LMW) proteinuria and aminoaciduria, overlap with those of Dent disease, a disorder that affects only the kidney. Mutations in OCRL account for ~20% of Dent disease patients. It has been proposed that derangements in phosphatidylinositol(4,5)P2 metabolism in LOCR causes defective receptor endocytosis, such as apical trafficking or recycling of megalin, a protein responsible for reabsorbing LMW proteins in the kidney proximal tubule. The CNS abnormalities could arise by analogous defects in recycling of certain CNS receptors. Testing these hypotheses is hampered by the lack of a mouse model because mice with a knock-out of Ocrl, the urine homolog of OCRL, have no detectable phenotype. We have shown that the lack of renal phenotype in Ocrl-knockout mice is due to complete compensation by another phosphatidylinositol(4,5)P2 5-phosphatase, Inpp5b, encoded by murine Inpp5b and mouse INPP5B. Mice with a mutation in Inpp5b have only a mild phenotype but mutation of both Ocrl and Inpp5b causes early embryonic lethality, indicating functional overlap. INPP5B and Inpp5b have clear differences in transcription and splicing which could explain why INPP5B only partially compensates for loss of human OCRL while mouse Inpp5b completely compensates. We created transgenic mice deleted for both murine Ocrl and Inpp5b and hemizygous for a bacterial artificial chromosome (BAC) containing INPP5B, and found they have delayed growth and the proximal renal tubular defects seen in LOCR and Dent disease. Mice deleted for both murine Ocrl and Inpp5b and homozygous for the INPP5B-BAC insertion grow more normally and excrete much less LMW protein. We conclude that there is both a qualitative and quantitative difference in the ability of INPP5B and Inpp5b to compensate for loss of Ocrl in mice. In this current application, we propose to culture proximal tubular cells from these strains of mice and correlate INPP5B enzyme activity with subcelular levels of phosphatidylinositol(4,5)P2 and altered renal transport of low molecular weight proteins and amino acids. We will also use recombination in mouse embryonic stem cells to dissect and identify the differences between INPP5B and Inpp5b responsible for the difference in phenotype between Ocrl-deficient humans and mice. Finally, after completing a 10-generation backcross onto C57Bl/6, we will examine the mice for abnormalities in central nervous system by testing motor function, anxiety, learning, memory and by examining the brains neuropathologically.
描述(申请人提供):Lowe OculoCerebroRenal综合征(LOCR)是一种罕见的X连锁先天性白内障、智力低下、行为异常和肾小管病变。这种疾病是由OCRL基因功能丧失突变引起的,OCRL基因编码OCRL,一种位于反高尔基网络的磷脂酰肌醇(4,5)P2 5-磷酸酶,内体,质膜褶皱和笼蛋白包裹的凹坑。LOCR的肾小管异常,特别是低分子(LMW)蛋白尿和氨基酸酸尿,与Dent病的肾小管异常重叠,Dent病只影响肾脏。OCRL基因突变约占Dent病患者的20%。已有研究表明,LOCR中磷脂酰肌醇(4,5)P2代谢的紊乱导致受体内吞功能缺陷,如顶端转运或回收megalin,这是一种负责在肾脏近端小管重新吸收LMW蛋白的蛋白质。中枢神经系统异常可能是由于某些中枢神经系统受体在循环过程中出现类似的缺陷而引起的。由于缺乏小鼠模型,这些假说的验证受到阻碍,因为OCRL(尿液中OCRL的同源物)基因敲除的小鼠没有可检测到的表型。我们已经证明,Ocr1基因敲除小鼠的肾脏表型缺失是由于另一种由小鼠Inpp5b和小鼠INPP5B编码的磷脂酰肌醇(4,5)P2 5-磷酸酶Inpp5b完全补偿所致。Inpp5b突变的小鼠只有轻微的表型,但Ocr1和Inpp5b的突变都会导致早期胚胎死亡,这表明功能重叠。INPP5B和Inpp5b在转录和剪接方面有明显的差异,这可以解释为什么INPP5B只能部分补偿人OCRL的丢失,而小鼠Inpp5b可以完全补偿。我们创造了同时缺失小鼠Ocr1和Inpp5b的转基因小鼠,以及含有INPP5B的细菌人工染色体(BAC)的半合子转基因小鼠,发现它们生长延迟,并出现LOCR和Dent病中出现的近端肾小管缺陷。同时缺失小鼠Ocr1和Inpp5b以及INPP5B-BAC插入纯合的小鼠生长更正常,分泌的LMW蛋白要少得多。我们的结论是,INPP5b和Inpp5b在小鼠体内补偿Ocr1丢失的能力存在质的和量的差异。在目前的应用中,我们建议从这些品系的小鼠中培养近端肾小管细胞,并将INPP5B酶的活性与磷脂酰肌醇(4,5)P2的胞下水平以及低分子蛋白质和氨基酸在肾脏的转运改变相关联。我们还将利用小鼠胚胎干细胞中的重组来解剖和鉴定INPP5b和Inpp5b之间的差异,这些差异是导致Ocr1缺乏症人类和小鼠表型差异的原因。最后,在完成了对C57BL/6的10代回交后,我们将通过测试运动功能、焦虑、学习、记忆和脑神经病理检查来检查小鼠中枢神经系统的异常。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT L NUSSBAUM其他文献

ROBERT L NUSSBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT L NUSSBAUM', 18)}}的其他基金

Sequencing of Newborn Blood Spot DNA to Improve and Expand Newborn Screening
新生儿血斑 DNA 测序可改善和扩大新生儿筛查
  • 批准号:
    8882899
  • 财政年份:
    2013
  • 资助金额:
    $ 33.6万
  • 项目类别:
Sequencing of Newborn Blood Spot DNA to Improve and Expand Newborn Screening
新生儿血斑 DNA 测序可改善和扩大新生儿筛查
  • 批准号:
    8584413
  • 财政年份:
    2013
  • 资助金额:
    $ 33.6万
  • 项目类别:
Sequencing of Newborn Blood Spot DNA to Improve and Expand Newborn Screening
新生儿血斑 DNA 测序可改善和扩大新生儿筛查
  • 批准号:
    8891509
  • 财政年份:
    2013
  • 资助金额:
    $ 33.6万
  • 项目类别:
Combined BAC Transgenic and Knock-Out Mouse Model of Lowe Syndrome Nephropathy
Lowe 综合征肾病的 BAC 转基因和敲除小鼠模型相结合
  • 批准号:
    8449266
  • 财政年份:
    2012
  • 资助金额:
    $ 33.6万
  • 项目类别:
Combined BAC Transgenic and Knock-Out Mouse Model of Lowe Syndrome Nephropathy
Lowe 综合征肾病的 BAC 转基因和敲除小鼠模型相结合
  • 批准号:
    8236723
  • 财政年份:
    2012
  • 资助金额:
    $ 33.6万
  • 项目类别:
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
  • 批准号:
    8305727
  • 财政年份:
    2010
  • 资助金额:
    $ 33.6万
  • 项目类别:
Combined BAC Transgenic and Knock-Out Mouse Model of Lowe Syndrome Nephropathy
Lowe 综合征肾病的 BAC 转基因和敲除小鼠模型相结合
  • 批准号:
    8081385
  • 财政年份:
    2010
  • 资助金额:
    $ 33.6万
  • 项目类别:
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
  • 批准号:
    8107578
  • 财政年份:
    2010
  • 资助金额:
    $ 33.6万
  • 项目类别:
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
胃肠道内毒素作为 α-突触核蛋白转基因小鼠的环境触发因素
  • 批准号:
    7985599
  • 财政年份:
    2010
  • 资助金额:
    $ 33.6万
  • 项目类别:
Glucocerebrosidase mutations in a mouse synucleinopathy model
小鼠突触核蛋白病模型中的葡萄糖脑苷脂酶突变
  • 批准号:
    7777864
  • 财政年份:
    2009
  • 资助金额:
    $ 33.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了